Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 6Breast 3Lymphoid 2Endocrine 2Tumor-Agnostic 1Other hematologic neoplasm 1Other 1Head & Neck 1Gynecologic 1

Conditions

Zollinger-Ellison Syndrome 1Multiple Endocrine Neoplasia 1Carcinoma, Neuroendocrine 1Carcinoid Tumor 1

Interventions

Everolimus 59lutetium Lu 177 dotatate 46Magnetic Resonance Spectroscopy 33pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 24lanreotide 23cabozantinib 22pasireotide 21gallium Ga 68 dotatate 21lenvatinib 20Etoposide 19Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18Sunitinib 17Bevacizumab 16trametinib 15dabrafenib 15Doxorubicin 143-Iodobenzylguanidine 14surufatinib 13Sorafenib 13Ipilimumab 13Thyrotropin Alfa 12Injections 12Positron Emission Tomography Computed Tomography 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Lansoprazole × Endocrine × Clear all
NCT01216267 2013-01-16

Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples

University of Western Ontario, Canada

Phase NA Completed
200 enrolled
Endocrine

Carcinoid Tumor, Carcinoma, Neuroendocrine

NCT00204373 2012-10-30

Treatment of Zollinger-Ellison Syndrome With Prevacid

University of Alabama at Birmingham

Phase 4 Completed
72 enrolled 8 charts
Endocrine

Multiple Endocrine Neoplasia, Zollinger-Ellison Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡